Filing Details
- Accession Number:
- 0001493152-15-006115
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-12-08 11:30:26
- Reporting Period:
- 2015-11-27
- Filing Date:
- 2015-12-08
- Accepted Time:
- 2015-12-08 11:30:26
- Original Submission Date:
- 2015-11-30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1459632 | S Mark Leventhal | 621 N. Shady Retreat Road Doylestown PA 18901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0005 | Acquisiton | 2015-11-27 | 13,300 | $1.55 | 881,032 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.0005 | Acquisiton | 2015-11-30 | 948 | $1.48 | 881,980 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- This amended filing is being made to change the transaction code from the original "A" designation to a "P" designation to align with the description of the transactions disclosed in the original Form 4 filings as filed on November 30, 2015.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.56, inclusive.
- These shares were purchased in a single transaction at a price of $1.48.
Billionaire Hedge Funds
